Potential response to curcumin in infantile hemangioendothelioma of the liver

A case of life‐threatening infantile hemangioendothelioma of the liver in a 6‐month‐old infant treated successfully with the dietary supplement curcumin is reported, with 6‐year follow‐up. Implications for pathogenesis based on sites of action of curcumin are considered. Pediatr Blood Cancer. 2010;5...

Full description

Saved in:
Bibliographic Details
Published in:Pediatric blood & cancer 2010-08, Vol.55 (2), p.377-379
Main Authors: Hassell, Lewis A., Roanh, Le Dinh
Format: Article
Language:English
Subjects:
angiogenesis factors
Anti-Inflammatory Agents, Non-Steroidal
Antineoplastic Agents
curcumin
Curcumin - therapeutic use
Diagnostic Imaging
Dietary Supplements
Hemangioendothelioma - drug therapy
Hemangioendothelioma - pathology
Humans
Infant
infantile hemangioendothelioma of liver
Liver Neoplasms - drug therapy
Liver Neoplasms - pathology
Remission Induction
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A case of life‐threatening infantile hemangioendothelioma of the liver in a 6‐month‐old infant treated successfully with the dietary supplement curcumin is reported, with 6‐year follow‐up. Implications for pathogenesis based on sites of action of curcumin are considered. Pediatr Blood Cancer. 2010;55:377–379. © 2010 Wiley–Liss, Inc.
ISSN:1545-5009
1545-5017
DOI:10.1002/pbc.22538